Skip to main content

Fixing the misfolded proteins that cause dementia and heart failure

All proteins have a correct way of “folding” themselves into their 3D structures. When this folding process goes awry, including processes leading to protein misassembly, a number of devastating diseases can result. In this Front Row lecture, Scripps Research professor Jeffery Kelly shared how he's developing novel therapeutic strategies to target these protein misfolding diseases, which lead to deterioration of the heart and brain. His multi-disciplinary research has already led to the development of an FDA-approved drug available in the pharmacy called tafamidis (Vyndaqel® and Vyndamax®): a medicine that slows the progression of the neurodegenerative disease familial amyloid polyneuropathy and the degenerative heart disease called TTR cardiomyopathy.

Front Row Lecture Series | Events

Drug Discovery Events Front Row Lecture Series Heart Disease Neurological Disorders

Groundbreaking Science.
Life-changing Medicine.